Navigation path

HOME
Policy areas
Sectors
Who is in charge?
Competition and you
Cases
In this section:
Overview
What's new?
Official Journal
Legislation >
Cases
Statistics
Publications (Antitrust and Cartels)
Leniency
Whistleblower
Settlement
Compliance (Antitrust)
Practical information (Antitrust and Cartels)

Antitrust/Cartels

Antitrust/Cartel Cases

39685 Fentanyl

Companies: Janssen-Cilag BV / Johnson & Johnson / Novartis / Sandoz BV
Economic Activity: C.21.20 - Manufacture of pharmaceutical preparations
G.46.46 - Wholesale of pharmaceutical goods
Events:
Date Document Type Document
29.04.2015 Second Advisory Committee Second Advisory Committee:
Multilingual
29.04.2015 Report of the Hearing Officer Final Report of the Hearing Officer:
Multilingual
29.04.2015 Summary Decision Summary of the Decision:
Multilingual
29.04.2015 First Advisory Committee First Advisory Committee:
Multilingual
10.12.2013 Prohibition Decision (Art. 101 Ex 81) en pdf  Published on 05.03.2015
10.12.2013 No Public Version available en pdf
10.12.2013 Press Release Commission fines Johnson & Johnson and Novartis € 16 million for delaying market entry of generic pain-killer fentanyl:
en
31.01.2013 Press Release Commission sends Statement of Objections to J&J and Novartis on delayed entry of generic pain-killer:
en
21.10.2011 Press Release Commission opens proceedings against Johnson & Johnson and Novartis:
en
18.10.2011 Opening of Proceedings en pdf
These publications are for information purposes only and should not be considered as an official publication

New Search

Help on how to use the case search tool